Eli Lilly and Company
Everything’s in place for women to do well at this pharmaceutical company, from a robust succession program with high-level mentoring and leadership training to senior management’s annual performance objectives, which require them to actively facilitate the development of female talent. The president of the company’s Bio-Medicines business unit has made advancing women a particular priority of his. It’s due in part to his inclusive approach—as well as a company mandate that specifies diverse candidates must be submitted for all available sales and marketing positions—that women now earn at least 43% of annual management promotions worldwide.
Chairman, President & CEO: John Lechleiter, PhD
Senior VP, HR & Diversity: Stephen Fry
% of senior managers who are women: 31%
% of corporate executives who are women: 21%
% of the top 10% of the company’s earners who are women: 29%
% of corporate executives with profit-and-loss responsibility who are women: 20%
% of the executives running divisions with revenues of more than a billion dollars who are women: 31%
% of executives who report directly to the CEO who are women: 31%
% of the members of the board of directors who are women: 29%



facebook
twitter
rss 

